Skip to main content
Premium Trial:

Request an Annual Quote

Berlex Licenses GeneGo s MetaCore Pathway Analysis Platform

NEW YORK, March 13 (GenomeWeb News) - GeneGo said today that Schering's US affiliate Berlex has licensed its MetaCore pathway analysis platform.

 

Reserchers at Berlex will use the MetaCore platform to analyze gene expression, proteomic, metabolic and other data in multiple therapeutic areas, including oncology, and in diagnostic applications, GeneGo said.

 

Financial terms of the agreement were not provided.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.